Cite

HARVARD Citation

    Facchinetti, F. et al. (2019). Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?. Immunotherapy. pp. 161-166. [Online]. 
  
Back to record